All
Research
Education
研究
教育
Business
解決策
JA
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
サインイン
Epigenetics Group,
Cancer Research Program,
Epigenetics Group, Cancer Research Program
Kate Patterson has not added Biography.
If you are Kate Patterson and would like to personalize this page please email our Author Liaison for assistance.
Vaccine for cervical cancer: reaching adolescents in sub-Saharan Africa.
Lancet Apr, 2006 | Pubmed ID: 16631895
When activators repress and repressors activate: a qualitative analysis of the Shea-Ackers model.
Bulletin of mathematical biology Aug, 2008 | Pubmed ID: 18648889
Dual-specificity phosphatases: critical regulators with diverse cellular targets.
The Biochemical journal Mar, 2009 | Pubmed ID: 19228121
Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
Gynecologic oncology Aug, 2009 | Pubmed ID: 19450871
DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs.
Biochimica et biophysica acta Sep, 2010 | Pubmed ID: 20347885
Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer.
Cancer letters Jan, 2011 | Pubmed ID: 21075513
Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Jan, 2011 | Pubmed ID: 21098650
Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer.
Genome research Feb, 2012 | Pubmed ID: 21788347
Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers.
Cancer letters Dec, 2011 | Pubmed ID: 22155104
Garvan Institute of Medical Research
Kate Patterson*,1,
Laura Molloy*,1,
Wenjia Qu1,
Susan Clark1,2
1Epigenetics Group, Cancer Research Program, Garvan Institute of Medical Research,
2St Vincent's Clinical School, University of NSW
個人情報保護方針
利用規約
一般データ保護規則
お問い合わせ
図書館への推薦
JoVE ニュースレター
JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
著者
図書館員
アクセス
JoVEについて
JoVE Sitemap
Copyright © 2023 MyJoVE Corporation. All rights reserved
当社はcookieを使用しています。
「続行」をクリックすることで、当社のcookieへの同意となります。
さらに見る